Back to Database
Status published
Unknown
CVE-2023-26089
European Chemicals Agency IUCLID 6.x before 6.27.6 allows authentication bypass...
Vulnerability Description
European Chemicals Agency IUCLID 6.x before 6.27.6 allows authentication bypass because a weak hard-coded secret is used for JWT signing. The affected versions are 5.15.0 through 6.27.5.
Impact Analysis
Refer to official advisory for detailed impact metrics.
Remediation
Ensure systems are updated to the latest vendor-supplied patch levels.
THREAT MONITOR
Am I Vulnerable?
Launch our assessment wizard to check if your infrastructure is exposed to • CVE-2023-26089
Credits & Attribution
No credits recorded in the NVD database.
References
More from n/a
View All →CVE-2025-9910
Versions of the package jsondiffpatch before 0.7.2 are vulnerable to...
Low
2.3
CVE-2025-9802
RemoteClinic profile.php sql injection
Medium
5.1
CVE-2025-9799
Langfuse Webhook promptRouter.ts promptChangeEventSourcing server-side request forgery
Low
2.3
CVE-2025-9775
RemoteClinic edit-my-profile.php unrestricted upload
Medium
6.9
CVE-2025-9774
RemoteClinic edit-patient.php information disclosure
Medium
5.3
Affected Vendor
Affected Software
Unknown
Vulnerable Versions:
Unknown
Timeline
Official Publish:
May 2nd, 2023
Last Modified:
January 30th, 2025
Added to House:
July 22nd, 2026
CVSS Vectors
No vector data available
Weaknesses (CWE)
No CWE data available
MITRE ATT&CK TTPs
No associated TTPs found for this vulnerability.